🇺🇸 FDA
Patent

US 10898505

Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 10898505 (Reagents for treatment of hepatitis B virus (HBV) infection and use thereof) held by Benitec Biopharma Limited expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Benitec Biopharma Limited
Grant date
Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7105, A61K31/713, A61K48/005, A61P